I wonder how many of the children who died were on some type of steroid treatment for asthma?
As far as "healthy" people being affected? What is their definition of healthy? You can have someone who appears to be healthy, but can currently be undergoing a lot of stress, which would depress the immune system, or could be a walking toxic dump because of their lifestyle...truly healthy people usually are not affected by disease. Someone related disease to mosquitos, mosquitos are not drawn to clean water, only stagnant water.
As far as Strep A complications being on the rise,
something to consider, when a vaccine is in the works, suddenly the targeted illnesses get on the required reporting list, as evidenced in the article you linked,
"Health officials have no explanation yet for the apparent surge, but McBride said it may be partly attributable to the fact that doctors have only been required to report the illness to state officials for the past two or three years."
Same thing happened when the varicella vaccine was in development, they began tracking varicella deaths so they could "prove" the need for the vaccine. Create the need, then fill it. Sounds like the same thing going on with the strep a publicity...
"These THREE BILLION DOLLAR 'BLOCKBUSTER' vaccine opportunities of ID Biomedical(TSE: IDB; NASDAQ: IDBE) are enough to excite the investor:"
"StreptAvax: A Potential Monopoly Vaccine Against 'Strep Throat'!
Prevnar, a multi-strain universal childhood vaccine, scored a whopping $500 million in revenue in its first year alone, which was more than any other pharmaceutical, or vaccine, launched that year. It now has revenues over $1 billion, and is still growing. That vaccine targets strep. pneumonia, which has a similar disease burden profile to IDBE's multi-strain vaccine against group A strep, StreptAvax, but it targets a different bacteria all together."http://www.stockhouse.com/bullboards...ll=0&TableID=2
"There were attempts to develop a group A strep vaccine for many, many years but there were major safety issues with developing those vaccines. These modern vaccines have been able to be designed to overcome some of the concerns of previous vaccines." In her study, the vaccine was given to 28 healthy adults between ages 18 and 50 years of age. There are about 90 different types of group A strep. This study evaluated just six types of strep. Researchers combined those six types of strep into a single vaccine and gave it to the volunteers to see if a vaccine could indeed be safe, well-tolerated and effective. Results of the study show the vaccine produced an immune response in all of the volunteers. It was also safe. With the excitement of these study results, researchers are now studying a vaccine that contains 26 of the 90 types of strep. Dr. Kotloff says, "That should cover about 85 percent of the serious group A strep infections that occur in North and South America." That vaccine is currently being studied in more and younger people. Dr. Kotloff says if that study proves successful, the vaccine could soon become a standard part of routine childhood vaccinations."http://abclocal.go.com/kgo/story?sec...ell&id=3946255
Read more about it,http://www.prnewswire.co.uk/cgi/news/release?id=39116